Redefining the role of adjuvant versus salvage radiation therapy for prostate cancer after radical prostatectomy for T3 disease and/or positive margins.

Authors

null

Barry W. Goy

Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA

Barry W. Goy , In-Lu Amy Liu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 367)

Abstract #

367

Poster Bd #

C19

Abstract Disclosures

Similar Posters

Poster

2019 Genitourinary Cancers Symposium

Survival outcomes for adjuvant or salvage radiation in men with pN+M0 prostate cancer.

Survival outcomes for adjuvant or salvage radiation in men with pN+M0 prostate cancer.

First Author: Jonathan David Tward

First Author: Jeremie Calais

First Author: William L. Hwang

Poster

2018 Genitourinary Cancers Symposium

Immunotherapy for biochemically recurrent prostate cancer.

Immunotherapy for biochemically recurrent prostate cancer.

First Author: Ravi Amrit Madan